Oldest pages

Jump to: navigation, search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Risks and rates‏‎ (19:40, 18 December 2022)
  2. Privacy policy‏‎ (17:16, 29 December 2022)
  3. About‏‎ (17:25, 29 December 2022)
  4. Choosing an appropriate type of map‏‎ (20:18, 22 March 2023)
  5. Spatial Analysis (Geographical Information Systems)‏‎ (20:21, 22 March 2023)
  6. Methods for setting thresholds in time series analysis‏‎ (20:23, 22 March 2023)
  7. Criteria for Surveillance‏‎ (20:33, 22 March 2023)
  8. Objectives of Surveillance‏‎ (20:34, 22 March 2023)
  9. Surveillance or Research‏‎ (20:34, 22 March 2023)
  10. Sources and Types of Data‏‎ (20:41, 22 March 2023)
  11. Quality checking‏‎ (20:42, 22 March 2023)
  12. Key definitions in infectious diseases epidemiology‏‎ (20:48, 22 March 2023)
  13. Measures of association‏‎ (21:00, 22 March 2023)
  14. Types of Cluster‏‎ (21:03, 22 March 2023)
  15. Impact numbers‏‎ (21:03, 22 March 2023)
  16. Measures of impact among the exposed‏‎ (21:06, 22 March 2023)
  17. Quantifying disease burden‏‎ (21:07, 22 March 2023)
  18. Incidence rate‏‎ (21:10, 22 March 2023)
  19. Relation between risk and incidence rate‏‎ (21:12, 22 March 2023)
  20. Risks and Rates‏‎ (21:13, 22 March 2023)
  21. Probability‏‎ (21:15, 22 March 2023)
  22. Preventing bias‏‎ (21:23, 22 March 2023)
  23. Confounding in studies‏‎ (21:26, 22 March 2023)
  24. Criteria for confounding‏‎ (21:27, 22 March 2023)
  25. Dose Effect‏‎ (21:27, 22 March 2023)
  26. Effect Modification‏‎ (21:27, 22 March 2023)
  27. Residual Confounding‏‎ (21:28, 22 March 2023)
  28. Presenting Data‏‎ (22:18, 22 March 2023)
  29. Disasters and Emergencies‏‎ (22:20, 22 March 2023)
  30. Health care settings‏‎ (22:20, 22 March 2023)
  31. Possible Terrorist / Deliberate Event‏‎ (22:20, 22 March 2023)
  32. Measures of disease impact - Further reading‏‎ (22:39, 22 March 2023)
  33. Health advocacy‏‎ (23:30, 22 March 2023)
  34. Bioinformatics‏‎ (11:10, 23 March 2023)
  35. Expert Advice‏‎ (11:10, 23 March 2023)
  36. Presenting Statistics‏‎ (11:23, 23 March 2023)
  37. Burden of HAIs‏‎ (12:21, 23 March 2023)
  38. Bone and Joint Infection‏‎ (12:56, 23 March 2023)
  39. Eye, Ear, Nose or Mouth Infection‏‎ (12:58, 23 March 2023)
  40. Gastrointestinal System Infections‏‎ (12:58, 23 March 2023)
  41. Lower Respiratory Tract Infection other than pneumonia‏‎ (12:58, 23 March 2023)
  42. Reproductive Tract Infections‏‎ (12:59, 23 March 2023)
  43. Skin and Soft Tissue Infections‏‎ (12:59, 23 March 2023)
  44. Specific Neonatal Case definitions‏‎ (13:00, 23 March 2023)
  45. Surgical Site Infection‏‎ (13:00, 23 March 2023)
  46. Systemic Infections‏‎ (13:01, 23 March 2023)
  47. Urinary Tract Infection‏‎ (13:01, 23 March 2023)
  48. ECDC point prevalence survey of healthcare-associated infections and antimicrobial use in long term care facilities‏‎ (13:02, 23 March 2023)
  49. ECDC surveillance of Surgical Site Infections‏‎ (13:03, 23 March 2023)
  50. Surveillance of Clostridium difficile infections‏‎ (13:04, 23 March 2023)
  51. Surveillance of HAIs in intensive care units‏‎ (13:04, 23 March 2023)
  52. The European Surveillance System (TESSy)‏‎ (13:04, 23 March 2023)
  53. Antimicrobial stewardship‏‎ (13:40, 23 March 2023)
  54. Antimicrobial resistance‏‎ (13:57, 23 March 2023)
  55. Cooperative learning as active learning in adult‏‎ (14:46, 23 March 2023)
  56. Education and training of staff‏‎ (14:52, 23 March 2023)
  57. Multidrug-resistant organisms (MDRO)‏‎ (15:07, 23 March 2023)
  58. CAUTI‏‎ (15:20, 23 March 2023)
  59. SSI‏‎ (15:39, 23 March 2023)
  60. Cohorting patients and/or staff‏‎ (15:55, 23 March 2023)
  61. Contact precautions‏‎ (16:00, 23 March 2023)
  62. Developing infection control interventions: isolation‏‎ (16:07, 23 March 2023)
  63. Gloves and hand hygiene‏‎ (16:33, 23 March 2023)
  64. Five moments for hand hygiene‏‎ (16:43, 23 March 2023)
  65. Hand hygiene for patients and visitors‏‎ (16:54, 23 March 2023)
  66. Indications for hand hygiene‏‎ (16:59, 23 March 2023)
  67. Hand hygiene methods‏‎ (17:20, 23 March 2023)
  68. Aesthetic preferences‏‎ (18:52, 23 March 2023)
  69. Evaluation of the microbicidal activities of hand-rub and hand-wash agents‏‎ (18:54, 23 March 2023)
  70. Pilot testing‏‎ (18:59, 23 March 2023)
  71. Product accessibility and cost‏‎ (19:03, 23 March 2023)
  72. Microbial flora of the hands‏‎ (19:13, 23 March 2023)
  73. Nails, rings, watches, bracelets‏‎ (19:16, 23 March 2023)
  74. Skin care‏‎ (19:17, 23 March 2023)
  75. Methods for assessing environmental cleanliness‏‎ (19:46, 23 March 2023)
  76. Microbial typing‏‎ (20:10, 23 March 2023)
  77. Molecular epidemiology‏‎ (20:16, 23 March 2023)
  78. Standard precautions‏‎ (20:39, 23 March 2023)
  79. Stage 0: Preparation for rapid risk assessment‏‎ (10:34, 24 March 2023)
  80. Stage 1: Collecting event information‏‎ (10:38, 24 March 2023)
  81. Stage 2: Systematically collecting information‏‎ (10:38, 24 March 2023)
  82. Stage 3: Extracting relevant evidence‏‎ (10:38, 24 March 2023)
  83. Stage 4: Appraising evidence‏‎ (10:39, 24 March 2023)
  84. Stage 5; Estimating the risk‏‎ (10:39, 24 March 2023)
  85. Model building strategies‏‎ (20:22, 25 March 2023)
  86. The Mantel Haenszel Method‏‎ (20:53, 25 March 2023)
  87. Confidence Intervals‏‎ (21:16, 25 March 2023)
  88. Significant probability to be different from the expected‏‎ (21:24, 25 March 2023)
  89. The idea of Statistical Inference‏‎ (21:30, 25 March 2023)
  90. Apps for epidemiologists‏‎ (14:43, 26 March 2023)
  91. Software for epidemiologists‏‎ (15:12, 26 March 2023)
  92. Weblinks for epidemiologists‏‎ (15:17, 26 March 2023)
  93. Host tracing‏‎ (16:45, 26 March 2023)
  94. Reservoir for infectious agents‏‎ (19:49, 26 March 2023)
  95. Source of infection‏‎ (19:50, 26 March 2023)
  96. Transmission routes‏‎ (19:58, 26 March 2023)
  97. Hygiene and Sanitation‏‎ (20:02, 26 March 2023)
  98. Herd immunity‏‎ (20:04, 26 March 2023)
  99. Measuring protection‏‎ (20:05, 26 March 2023)
  100. Primary prevention‏‎ (20:23, 26 March 2023)
  101. Secondary prevention‏‎ (20:28, 26 March 2023)
  102. Tertiary prevention‏‎ (20:31, 26 March 2023)
  103. EU Food Safety Legislation‏‎ (20:58, 26 March 2023)
  104. EU Legislation for Communicable Diseases Surveillance‏‎ (21:03, 26 March 2023)
  105. Applying Epidemiology for the International Health Regulations.‏‎ (21:09, 26 March 2023)
  106. Social marketing‏‎ (08:36, 27 March 2023)
  107. Outbreak communication‏‎ (08:39, 27 March 2023)
  108. Health literacy‏‎ (08:49, 27 March 2023)
  109. Measures of Accuracy in Screening‏‎ (16:59, 28 March 2023)
  110. The outbreak management team‏‎ (17:34, 28 March 2023)
  111. Defining a Case‏‎ (22:03, 28 March 2023)
  112. Sensitivity and Specificity of a case definition‏‎ (22:12, 28 March 2023)
  113. Various Levels of Case Definition‏‎ (22:21, 28 March 2023)
  114. Identifying Multiple Possible Outbreak Sources‏‎ (04:51, 29 March 2023)
  115. Unmasking Outbreak Source through Segmentation‏‎ (04:58, 29 March 2023)
  116. Distinguishing Different Sources or Modes of Transmission during an outbreak‏‎ (06:23, 29 March 2023)
  117. Diagnostic Applications of the Epidemic Curve‏‎ (06:28, 29 March 2023)
  118. Additional resources for presenting findings‏‎ (06:32, 29 March 2023)
  119. Tables‏‎ (07:03, 29 March 2023)
  120. Frequency polygons‏‎ (07:37, 29 March 2023)
  121. Line graphs‏‎ (07:55, 29 March 2023)
  122. Structure of an Outbreak Investigation Report‏‎ (08:30, 29 March 2023)
  123. SOCO (single over-riding communications objective)‏‎ (08:41, 29 March 2023)
  124. Use of computers‏‎ (08:46, 29 March 2023)
  125. Outbreak steps : additional points‏‎ (09:49, 29 March 2023)
  126. Glossary‏‎ (10:27, 29 March 2023)
  127. Receiver operating curve‏‎ (18:57, 29 March 2023)
  128. Validity and accuracy‏‎ (19:25, 29 March 2023)
  129. Analysis by person characteristics‏‎ (19:37, 29 March 2023)
  130. SMART definitions‏‎ (22:14, 29 March 2023)
  131. Detection Bias‏‎ (18:33, 30 March 2023)
  132. Advantages and disadvantages of matching‏‎ (18:44, 30 March 2023)
  133. Restriction‏‎ (18:53, 30 March 2023)
  134. Table format and Analysis‏‎ (19:15, 30 March 2023)
  135. Analytical Study Designs‏‎ (20:00, 30 March 2023)
  136. Cross-sectional Studies‏‎ (20:16, 30 March 2023)
  137. Measures of effect in various study designs‏‎ (20:23, 30 March 2023)
  138. Measuring risk‏‎ (20:55, 30 March 2023)
  139. Cost-effectiveness‏‎ (17:58, 2 April 2023)
  140. Cost-minimisation‏‎ (18:13, 2 April 2023)
  141. Cost-utility‏‎ (18:21, 2 April 2023)
  142. Sensitivity Analysis‏‎ (19:00, 2 April 2023)
  143. Test Reproducibility‏‎ (14:25, 6 April 2023)
  144. Person to Person‏‎ (15:01, 6 April 2023)
  145. Antigen presenting cells (APC)‏‎ (16:55, 6 April 2023)
  146. Antigens (Ag)‏‎ (17:00, 6 April 2023)
  147. Helminthic mechanisms of immune evasion‏‎ (17:02, 6 April 2023)
  148. Mechanism of infectious disease‏‎ (17:03, 6 April 2023)
  149. What determines our susceptibility to infections?‏‎ (17:05, 6 April 2023)
  150. Practical Aspects of Specimen Collection and Shipment‏‎ (17:12, 6 April 2023)
  151. Types of Microorganisms‏‎ (17:19, 6 April 2023)
  152. Web-crawling Applications‏‎ (17:24, 6 April 2023)
  153. Table measuring risk, rate and odds ratio‏‎ (14:46, 8 April 2023)
  154. European Surveillance of Antimicrobial Consumption Network (ESAC-Net)‏‎ (19:51, 8 April 2023)
  155. European Antimicrobial Resistance Surveillance Network (EARS-Net)‏‎ (19:53, 8 April 2023)
  156. ECDC Programme on antimicrobial resistance and healthcare-associated infections‏‎ (19:58, 8 April 2023)
  157. Semmelweis‏‎ (20:45, 9 April 2023)
  158. Statistical Methods for Cluster Investigation‏‎ (21:48, 9 April 2023)
  159. Surveillance for MV Patients in the ICU‏‎ (18:11, 10 April 2023)
  160. Epidemiological/public health role of the clinical microbiology laboratory‏‎ (18:21, 10 April 2023)
  161. Surveillance methodologies for healthcare associated infections‏‎ (18:29, 10 April 2023)
  162. Ten Steps to Design a Questionnaire‏‎ (18:30, 10 April 2023)
  163. Piloting Questionnaires‏‎ (18:31, 10 April 2023)
  164. Bias in Questionnaires‏‎ (18:32, 10 April 2023)
  165. Density case control studies‏‎ (18:33, 10 April 2023)
  166. Checklist for study protocols‏‎ (18:38, 10 April 2023)
  167. Format of closed questions‏‎ (18:39, 10 April 2023)
  168. Viewpoints for Causality (Bradford Hill)‏‎ (18:42, 10 April 2023)
  169. Healthcare-Associated Infections Network (HAI-Net)‏‎ (18:42, 10 April 2023)
  170. Bar graphs‏‎ (18:44, 10 April 2023)
  171. Types of Questionnaires‏‎ (18:51, 10 April 2023)
  172. Validated questionnaires‏‎ (18:55, 10 April 2023)
  173. Event-based Surveillance‏‎ (19:08, 10 April 2023)
  174. Histograms‏‎ (21:03, 10 April 2023)
  175. Diagnostic tests versus screening test‏‎ (21:05, 10 April 2023)
  176. VAP‏‎ (21:07, 10 April 2023)
  177. Hand hygiene before invasive procedures‏‎ (21:08, 10 April 2023)
  178. Contact tracing‏‎ (21:08, 10 April 2023)
  179. Reprocessing of flexible endoscopes‏‎ (21:10, 10 April 2023)
  180. Principles of matching‏‎ (21:11, 10 April 2023)
  181. 10 common errors in surveillance evaluations‏‎ (21:13, 10 April 2023)
  182. Threshold setting‏‎ (21:13, 10 April 2023)
  183. Health education‏‎ (21:14, 10 April 2023)
  184. The logistic model‏‎ (21:15, 10 April 2023)
  185. Immunization of health care workers‏‎ (21:17, 10 April 2023)
  186. CLABSI‏‎ (21:18, 10 April 2023)
  187. Environment as a source of healthcare-associated infections‏‎ (21:19, 10 April 2023)
  188. Measures of impact in the population‏‎ (21:20, 10 April 2023)
  189. Interaction‏‎ (21:21, 10 April 2023)
  190. Selection and evaluation for specific products‏‎ (21:22, 10 April 2023)
  191. Interpreting model coefficients‏‎ (21:24, 10 April 2023)
  192. Analysis, Interpretation, and Dissemination‏‎ (21:25, 10 April 2023)
  193. Hospital cleaning and decontamination‏‎ (21:27, 10 April 2023)
  194. Health Informatics Standards - Health Information Systems and Processes‏‎ (21:29, 10 April 2023)
  195. Frequent Problems with writing an Outbreak Investigation Report‏‎ (21:30, 10 April 2023)
  196. Case-cohort study‏‎ (21:31, 10 April 2023)
  197. The Role of Surveillance‏‎ (21:32, 10 April 2023)
  198. Advantages and Disadvantages of Questionnaires‏‎ (21:32, 10 April 2023)
  199. Estimating Odds Ratios in the presence of interaction‏‎ (21:33, 10 April 2023)
  200. Pie charts‏‎ (21:34, 10 April 2023)
  201. Brief history of International Communicable Disease Law‏‎ (21:34, 10 April 2023)
  202. Antibodies‏‎ (21:34, 10 April 2023)
  203. Disentangling Complex Data‏‎ (21:35, 10 April 2023)
  204. Advantages and disadvantages of cohort and case control studies‏‎ (21:37, 10 April 2023)
  205. Parallel versus Serial testing‏‎ (21:37, 10 April 2023)
  206. Vector Borne‏‎ (21:38, 10 April 2023)
  207. Reference group for cohort studies‏‎ (21:40, 10 April 2023)
  208. Which indicator to map?‏‎ (21:41, 10 April 2023)
  209. Clinical role of the microbiology laboratory‏‎ (21:42, 10 April 2023)
  210. Types of variables and line listing‏‎ (21:43, 10 April 2023)
  211. Attack rate‏‎ (21:45, 10 April 2023)
  212. Pre-emptive isolation‏‎ (21:46, 10 April 2023)
  213. Linear models‏‎ (21:47, 10 April 2023)
  214. Risk communication‏‎ (21:48, 10 April 2023)
  215. Health Informatics Standards - Standard Content‏‎ (21:48, 10 April 2023)
  216. Test reliability‏‎ (21:49, 10 April 2023)
  217. Measuring incidence rates‏‎ (21:50, 10 April 2023)
  218. Selection bias and cohort studies‏‎ (21:50, 10 April 2023)
  219. Use of Epidemic Curves for characterising Outbreak Sources‏‎ (21:56, 10 April 2023)
  220. Smoothing techniques‏‎ (21:57, 10 April 2023)
  221. Outbreak investigations: 10 steps, 10 pitfalls‏‎ (22:00, 10 April 2023)
  222. The Components of Surveillance‏‎ (22:01, 10 April 2023)
  223. Acquired resistance‏‎ (22:02, 10 April 2023)
  224. Standardization of rates‏‎ (06:34, 11 April 2023)
  225. Other types of data display‏‎ (06:34, 11 April 2023)
  226. Case to case study design‏‎ (12:45, 11 April 2023)
  227. Writing for Stakeholders‏‎ (13:09, 11 April 2023)
  228. Checklist for posters‏‎ (13:16, 11 April 2023)
  229. Scientific paper review form‏‎ (13:42, 11 April 2023)
  230. Laboratory Support‏‎ (17:41, 11 April 2023)
  231. To Public and the Media‏‎ (17:42, 11 April 2023)
  232. Developing a control definition‏‎ (17:53, 11 April 2023)
  233. Interviewer Bias‏‎ (18:10, 11 April 2023)
  234. Recall Bias‏‎ (18:15, 11 April 2023)
  235. Reporting Bias‏‎ (18:49, 11 April 2023)
  236. Response Bias‏‎ (18:55, 11 April 2023)
  237. ECDC PPS in European acute care hospitals protocol‏‎ (19:01, 11 April 2023)
  238. ECDC PPS in European acute care hospitals, definition of HAI‏‎ (19:06, 11 April 2023)
  239. ECDC PPS - antimicrobial use definition‏‎ (19:11, 11 April 2023)
  240. ECDC PPS - inclusion/exclusion criteria‏‎ (19:15, 11 April 2023)
  241. Types of Surveillance System (Active vs Passive)‏‎ (19:27, 11 April 2023)
  242. Questionnaire Layout and Coding‏‎ (19:37, 11 April 2023)
  243. Seven Golden Rules to Design Questions‏‎ (19:49, 11 April 2023)
  244. FEM Users code of conduct‏‎ (06:07, 12 April 2023)
  245. Descriptive Studies‏‎ (06:16, 12 April 2023)
  246. Experimental Studies‏‎ (06:59, 12 April 2023)
  247. Capture-recapture‏‎ (13:19, 12 April 2023)
  248. Public health response (informing control)‏‎ (13:21, 12 April 2023)
  249. Interpreting Data‏‎ (13:22, 12 April 2023)
  250. Common errors in surveillance data analysis‏‎ (13:36, 12 April 2023)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)